小剂量瑞芬太尼联合意识指数监测在胃镜下息肉切除术中的效果:前瞻性随机单盲试验
结果显示随瑞芬太尼剂量增加,丙泊酚用量和苏醒时间显著减少,高血压和体动发生率下降,但低血压、心动过缓和低氧血症发生率上升;瑞芬太尼4 ng/mL为相对理想的目标浓度。
要点
- 瑞芬太尼4 ng/mL联合IOC监测在胃镜下息肉切除术中较为理想。
- 随瑞芬太尼剂量增加,丙泊酚用量和苏醒时间显著减少。
- 高剂量瑞芬太尼增加低血压、心动过缓和低氧血症风险。
核心结论
- 在IOC监测辅助下,瑞芬太尼目标浓度4 ng/mL在胃镜下息肉切除术患者中相对理想。
研究设计与样本
- 麻醉期间瑞芬太尼维持初始设定浓度,丙泊酚根据IOC1调整。
- 主要结局为丙泊酚和瑞芬太尼用量;次要结局包括IOC1和IOC2变化、苏醒时间及围术期不良反应。
主要发现
- 随着瑞芬太尼剂量增加,丙泊酚用量和患者苏醒时间显著减少。
- 随着瑞芬太尼剂量增加,高血压和体动发生率下降,但低血压、心动过缓和低氧血症发生率上升。
- R2组治疗期间IOC2值维持在50以上;R6组胃镜开始时IOC2降至30以下。
- R2组与R6组之间低氧血症发生率差异有统计学意义(P <0.05)。
关键数值与推荐
- 瑞芬太尼目标浓度4 ng/mL在胃镜下息肉切除术患者中相对理想。
- R2组与R6组低氧血症比较P <0.05。
临床怎么用
- 胃镜下息肉切除术中可考虑瑞芬太尼4 ng/mL联合IOC监测,兼顾镇静效果与安全性。
- 使用IOC监测有助于个体化调整丙泊酚用量并识别瑞芬太尼适宜剂量。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: With the development of painless diagnosis and treatment, remifentanil, a synthetic opioid agonist, is increasingly used in gastroscopy for its rapid, short-term, and potent analgesic effect. However, the dosage of remifentanil used in endoscopy is unclear. Index of consciousness (IOC) is a new anesthesia depth-monitoring indicator that can be divided into index of consciousness 1 (IOC1) and index of consciousness 2 (IOC2); IOC1 is used for estimating a patient's sedation state, whereas IOC2 reflects analgesic depth. We hypothesized that combining with IOC1 and IOC2 monitoring may be helpful to identify an optimal remifentanil dosage in gastroscopic polypectomy. METHODS: One hundred twenty patients scheduled for gastroscopic polypectomy were enrolled and were randomly assigned to remifentanil 2 ng/mL (group R2), 4 ng/mL (group R4), or 6 ng/mL (group R6), and 40 cases were in each group. During the anesthesia period, remifentanil was kept at the initial given concentration but propofol was adjusted according to IOC1. The primary outcomes were the dosage of propofol and remifentanil. The secondary outcomes were the variety of IOC1 and IOC2, patients' awakening time, and peri-operative adverse reactions such as hypotension, hypertension, bradycardia, tachycardia, body movements, hypoxemia, therapy interruption, nausea, vomiting, aspiration, and intra-operative awareness. RESULTS: With the increasing dosage of remifentanil, the propofol dosage and patients' awakening time decreased significantly, the morbidity of hypertension and body movements also declined, but the incidence of hypotension, bradycardia, and hypoxemia rose. In group R2, the value of IOC2 remained above 50 during the treatment. However, IOC2 dropped to below 30 at the beginning of the gastroscopy in group R6, and there was statistical difference in hypoxemia between groups R2 and R6 (P <0.05). CONCLUSIONS: With the help of IOC monitoring, we found that a target concentration of remifentanil 4 ng/mL is comparatively ideal in patients under gastroscopic polypectomy. TRIAL REGISTRATION: Chinese Clinical Trial Register: ChiCTR-OOD-16009489 , on October 19, 2016.
引用
- Liu M, Wu H, Yang D, et al. Effects of small-dose remifentanil combined with index of consciousness monitoring on gastroscopic polypectomy: a prospective, randomized, single-blinded trial. Trials. 2018. PMID: 30021625. doi:10.1186/s13063-018-2783-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。